Loading…

Effects of the stable prostacyclin analogue iloprost on the plasma disappearance rate of indocyanine green in human septic shock

To evaluate the effect of the stable prostacyclin analogue iloprost on the plasma disappearance rate of indocyanine green (PDR) in patients with septic shock. A prospective clinical study in a university hospital intensive care unit. 20 patients in septic shock. Patients received iloprost infusion (...

Full description

Saved in:
Bibliographic Details
Published in:Intensive care medicine 2000-10, Vol.26 (10), p.1557-1560
Main Authors: LEHMANN, Christian, TAYMOORIAN, Kasra, WAUER, Helmar, KRAUSCH, Dietmar, BIRNBAUM, Jürgen, KOX, Wolfgang J
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c345t-2e029666d8d99e33395afd34446f854780052f6ae534d475e6eaaedafc4d6fbd3
cites
container_end_page 1560
container_issue 10
container_start_page 1557
container_title Intensive care medicine
container_volume 26
creator LEHMANN, Christian
TAYMOORIAN, Kasra
WAUER, Helmar
KRAUSCH, Dietmar
BIRNBAUM, Jürgen
KOX, Wolfgang J
description To evaluate the effect of the stable prostacyclin analogue iloprost on the plasma disappearance rate of indocyanine green (PDR) in patients with septic shock. A prospective clinical study in a university hospital intensive care unit. 20 patients in septic shock. Patients received iloprost infusion (1 ng/kg per minute) for 24 h. PDR was determined by a femoral arterial fiberoptic catheter before, 1, 6, and 24 h after start and 1 h after end of iloprost infusion. PDR increased significantly 24 h after start of iloprost infusion (baseline: 13.9 +/- 1.7% vs. 18.6 +/- 2.2%/min) and decreased 1 h after end of infusion (13.7 +/- 1.7%/min; p < 0.002). There was no change in pHi, cardiac index, mean arterial pressure, heart rate, central venous pressure, or intrathoracic blood volume index. Administration of the stable prostacyclin analogue iloprost significantly increases PDR, indicating improvement in liver function.
doi_str_mv 10.1007/s001340000662
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72501571</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>72501571</sourcerecordid><originalsourceid>FETCH-LOGICAL-c345t-2e029666d8d99e33395afd34446f854780052f6ae534d475e6eaaedafc4d6fbd3</originalsourceid><addsrcrecordid>eNpd0c9LHDEUB_BQWupWPXotoZTeRvN7do4i9gcIXup5eJu8uNFMMp3MHPbmn25WF8TmkvDy4cH7PkLOODvnjLUXhTEuFavHGPGBrLiSouFCrj-SFZNKNMoocUS-lPJQZWs0_0yOOOfCiFasyNO192jnQrOn8xZpmWETkY5Tri-7szEkCglivl-QhphfPmhOL3iMUAagLhQYR4QJkkU6wYz7biG5bHeQQkJ6PyGmWqHbZYBEC45zsLRss308IZ88xIKnh_uY3P28_nv1u7m5_fXn6vKmsVLpuRHIRGeMcWvXdSil7DR4J5VSxq-1ateMaeENoJbKqVajQQB04K1yxm-cPCY_XvvWCf4tWOZ-CMVijJAwL6VvhWZct7zCb__Bh7xMNYLSd53UNWVmKmpeka15lAl9P05hgGnXc9bv99K_20v1Xw9Nl82A7k0fFlHB9wOAYiH6fZahvDktZJ1RPgOJ6ZX8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>993566206</pqid></control><display><type>article</type><title>Effects of the stable prostacyclin analogue iloprost on the plasma disappearance rate of indocyanine green in human septic shock</title><source>Springer Nature</source><creator>LEHMANN, Christian ; TAYMOORIAN, Kasra ; WAUER, Helmar ; KRAUSCH, Dietmar ; BIRNBAUM, Jürgen ; KOX, Wolfgang J</creator><creatorcontrib>LEHMANN, Christian ; TAYMOORIAN, Kasra ; WAUER, Helmar ; KRAUSCH, Dietmar ; BIRNBAUM, Jürgen ; KOX, Wolfgang J</creatorcontrib><description>To evaluate the effect of the stable prostacyclin analogue iloprost on the plasma disappearance rate of indocyanine green (PDR) in patients with septic shock. A prospective clinical study in a university hospital intensive care unit. 20 patients in septic shock. Patients received iloprost infusion (1 ng/kg per minute) for 24 h. PDR was determined by a femoral arterial fiberoptic catheter before, 1, 6, and 24 h after start and 1 h after end of iloprost infusion. PDR increased significantly 24 h after start of iloprost infusion (baseline: 13.9 +/- 1.7% vs. 18.6 +/- 2.2%/min) and decreased 1 h after end of infusion (13.7 +/- 1.7%/min; p &lt; 0.002). There was no change in pHi, cardiac index, mean arterial pressure, heart rate, central venous pressure, or intrathoracic blood volume index. Administration of the stable prostacyclin analogue iloprost significantly increases PDR, indicating improvement in liver function.</description><identifier>ISSN: 0342-4642</identifier><identifier>EISSN: 1432-1238</identifier><identifier>DOI: 10.1007/s001340000662</identifier><identifier>PMID: 11126272</identifier><identifier>CODEN: ICMED9</identifier><language>eng</language><publisher>Heidelberg: Springer</publisher><subject>Adult ; Aged ; Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy ; Biological and medical sciences ; Blood ; Catheters ; Coloring Agents - pharmacokinetics ; Drug Monitoring - instrumentation ; Drug Monitoring - methods ; Dye Dilution Technique - instrumentation ; Emergency and intensive care: infection, septic shock ; Epoprostenol - analogs &amp; derivatives ; Female ; Hemodynamics ; Humans ; Iloprost - pharmacology ; Iloprost - therapeutic use ; Indocyanine Green - pharmacokinetics ; Infusions, Intravenous ; Intensive care ; Intensive care medicine ; Leukocytes ; Liver ; Liver - metabolism ; Liver - physiopathology ; Liver Function Tests ; Male ; Medical sciences ; Metabolic Clearance Rate - drug effects ; Middle Aged ; Neutrophils ; Plasma ; Prospective Studies ; Sepsis ; Shock, Septic - drug therapy ; Shock, Septic - metabolism ; Shock, Septic - physiopathology ; Vasodilator Agents - pharmacology ; Vasodilator Agents - therapeutic use</subject><ispartof>Intensive care medicine, 2000-10, Vol.26 (10), p.1557-1560</ispartof><rights>2000 INIST-CNRS</rights><rights>Springer-Verlag 2000</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c345t-2e029666d8d99e33395afd34446f854780052f6ae534d475e6eaaedafc4d6fbd3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27922,27923</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1523780$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11126272$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>LEHMANN, Christian</creatorcontrib><creatorcontrib>TAYMOORIAN, Kasra</creatorcontrib><creatorcontrib>WAUER, Helmar</creatorcontrib><creatorcontrib>KRAUSCH, Dietmar</creatorcontrib><creatorcontrib>BIRNBAUM, Jürgen</creatorcontrib><creatorcontrib>KOX, Wolfgang J</creatorcontrib><title>Effects of the stable prostacyclin analogue iloprost on the plasma disappearance rate of indocyanine green in human septic shock</title><title>Intensive care medicine</title><addtitle>Intensive Care Med</addtitle><description>To evaluate the effect of the stable prostacyclin analogue iloprost on the plasma disappearance rate of indocyanine green (PDR) in patients with septic shock. A prospective clinical study in a university hospital intensive care unit. 20 patients in septic shock. Patients received iloprost infusion (1 ng/kg per minute) for 24 h. PDR was determined by a femoral arterial fiberoptic catheter before, 1, 6, and 24 h after start and 1 h after end of iloprost infusion. PDR increased significantly 24 h after start of iloprost infusion (baseline: 13.9 +/- 1.7% vs. 18.6 +/- 2.2%/min) and decreased 1 h after end of infusion (13.7 +/- 1.7%/min; p &lt; 0.002). There was no change in pHi, cardiac index, mean arterial pressure, heart rate, central venous pressure, or intrathoracic blood volume index. Administration of the stable prostacyclin analogue iloprost significantly increases PDR, indicating improvement in liver function.</description><subject>Adult</subject><subject>Aged</subject><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</subject><subject>Biological and medical sciences</subject><subject>Blood</subject><subject>Catheters</subject><subject>Coloring Agents - pharmacokinetics</subject><subject>Drug Monitoring - instrumentation</subject><subject>Drug Monitoring - methods</subject><subject>Dye Dilution Technique - instrumentation</subject><subject>Emergency and intensive care: infection, septic shock</subject><subject>Epoprostenol - analogs &amp; derivatives</subject><subject>Female</subject><subject>Hemodynamics</subject><subject>Humans</subject><subject>Iloprost - pharmacology</subject><subject>Iloprost - therapeutic use</subject><subject>Indocyanine Green - pharmacokinetics</subject><subject>Infusions, Intravenous</subject><subject>Intensive care</subject><subject>Intensive care medicine</subject><subject>Leukocytes</subject><subject>Liver</subject><subject>Liver - metabolism</subject><subject>Liver - physiopathology</subject><subject>Liver Function Tests</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Metabolic Clearance Rate - drug effects</subject><subject>Middle Aged</subject><subject>Neutrophils</subject><subject>Plasma</subject><subject>Prospective Studies</subject><subject>Sepsis</subject><subject>Shock, Septic - drug therapy</subject><subject>Shock, Septic - metabolism</subject><subject>Shock, Septic - physiopathology</subject><subject>Vasodilator Agents - pharmacology</subject><subject>Vasodilator Agents - therapeutic use</subject><issn>0342-4642</issn><issn>1432-1238</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><recordid>eNpd0c9LHDEUB_BQWupWPXotoZTeRvN7do4i9gcIXup5eJu8uNFMMp3MHPbmn25WF8TmkvDy4cH7PkLOODvnjLUXhTEuFavHGPGBrLiSouFCrj-SFZNKNMoocUS-lPJQZWs0_0yOOOfCiFasyNO192jnQrOn8xZpmWETkY5Tri-7szEkCglivl-QhphfPmhOL3iMUAagLhQYR4QJkkU6wYz7biG5bHeQQkJ6PyGmWqHbZYBEC45zsLRss308IZ88xIKnh_uY3P28_nv1u7m5_fXn6vKmsVLpuRHIRGeMcWvXdSil7DR4J5VSxq-1ateMaeENoJbKqVajQQB04K1yxm-cPCY_XvvWCf4tWOZ-CMVijJAwL6VvhWZct7zCb__Bh7xMNYLSd53UNWVmKmpeka15lAl9P05hgGnXc9bv99K_20v1Xw9Nl82A7k0fFlHB9wOAYiH6fZahvDktZJ1RPgOJ6ZX8</recordid><startdate>20001001</startdate><enddate>20001001</enddate><creator>LEHMANN, Christian</creator><creator>TAYMOORIAN, Kasra</creator><creator>WAUER, Helmar</creator><creator>KRAUSCH, Dietmar</creator><creator>BIRNBAUM, Jürgen</creator><creator>KOX, Wolfgang J</creator><general>Springer</general><general>Springer Nature B.V</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M7Z</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20001001</creationdate><title>Effects of the stable prostacyclin analogue iloprost on the plasma disappearance rate of indocyanine green in human septic shock</title><author>LEHMANN, Christian ; TAYMOORIAN, Kasra ; WAUER, Helmar ; KRAUSCH, Dietmar ; BIRNBAUM, Jürgen ; KOX, Wolfgang J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c345t-2e029666d8d99e33395afd34446f854780052f6ae534d475e6eaaedafc4d6fbd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</topic><topic>Biological and medical sciences</topic><topic>Blood</topic><topic>Catheters</topic><topic>Coloring Agents - pharmacokinetics</topic><topic>Drug Monitoring - instrumentation</topic><topic>Drug Monitoring - methods</topic><topic>Dye Dilution Technique - instrumentation</topic><topic>Emergency and intensive care: infection, septic shock</topic><topic>Epoprostenol - analogs &amp; derivatives</topic><topic>Female</topic><topic>Hemodynamics</topic><topic>Humans</topic><topic>Iloprost - pharmacology</topic><topic>Iloprost - therapeutic use</topic><topic>Indocyanine Green - pharmacokinetics</topic><topic>Infusions, Intravenous</topic><topic>Intensive care</topic><topic>Intensive care medicine</topic><topic>Leukocytes</topic><topic>Liver</topic><topic>Liver - metabolism</topic><topic>Liver - physiopathology</topic><topic>Liver Function Tests</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Metabolic Clearance Rate - drug effects</topic><topic>Middle Aged</topic><topic>Neutrophils</topic><topic>Plasma</topic><topic>Prospective Studies</topic><topic>Sepsis</topic><topic>Shock, Septic - drug therapy</topic><topic>Shock, Septic - metabolism</topic><topic>Shock, Septic - physiopathology</topic><topic>Vasodilator Agents - pharmacology</topic><topic>Vasodilator Agents - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>LEHMANN, Christian</creatorcontrib><creatorcontrib>TAYMOORIAN, Kasra</creatorcontrib><creatorcontrib>WAUER, Helmar</creatorcontrib><creatorcontrib>KRAUSCH, Dietmar</creatorcontrib><creatorcontrib>BIRNBAUM, Jürgen</creatorcontrib><creatorcontrib>KOX, Wolfgang J</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Proquest Nursing &amp; Allied Health Source</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biochemistry Abstracts 1</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Intensive care medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>LEHMANN, Christian</au><au>TAYMOORIAN, Kasra</au><au>WAUER, Helmar</au><au>KRAUSCH, Dietmar</au><au>BIRNBAUM, Jürgen</au><au>KOX, Wolfgang J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effects of the stable prostacyclin analogue iloprost on the plasma disappearance rate of indocyanine green in human septic shock</atitle><jtitle>Intensive care medicine</jtitle><addtitle>Intensive Care Med</addtitle><date>2000-10-01</date><risdate>2000</risdate><volume>26</volume><issue>10</issue><spage>1557</spage><epage>1560</epage><pages>1557-1560</pages><issn>0342-4642</issn><eissn>1432-1238</eissn><coden>ICMED9</coden><abstract>To evaluate the effect of the stable prostacyclin analogue iloprost on the plasma disappearance rate of indocyanine green (PDR) in patients with septic shock. A prospective clinical study in a university hospital intensive care unit. 20 patients in septic shock. Patients received iloprost infusion (1 ng/kg per minute) for 24 h. PDR was determined by a femoral arterial fiberoptic catheter before, 1, 6, and 24 h after start and 1 h after end of iloprost infusion. PDR increased significantly 24 h after start of iloprost infusion (baseline: 13.9 +/- 1.7% vs. 18.6 +/- 2.2%/min) and decreased 1 h after end of infusion (13.7 +/- 1.7%/min; p &lt; 0.002). There was no change in pHi, cardiac index, mean arterial pressure, heart rate, central venous pressure, or intrathoracic blood volume index. Administration of the stable prostacyclin analogue iloprost significantly increases PDR, indicating improvement in liver function.</abstract><cop>Heidelberg</cop><cop>Berlin</cop><pub>Springer</pub><pmid>11126272</pmid><doi>10.1007/s001340000662</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0342-4642
ispartof Intensive care medicine, 2000-10, Vol.26 (10), p.1557-1560
issn 0342-4642
1432-1238
language eng
recordid cdi_proquest_miscellaneous_72501571
source Springer Nature
subjects Adult
Aged
Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy
Biological and medical sciences
Blood
Catheters
Coloring Agents - pharmacokinetics
Drug Monitoring - instrumentation
Drug Monitoring - methods
Dye Dilution Technique - instrumentation
Emergency and intensive care: infection, septic shock
Epoprostenol - analogs & derivatives
Female
Hemodynamics
Humans
Iloprost - pharmacology
Iloprost - therapeutic use
Indocyanine Green - pharmacokinetics
Infusions, Intravenous
Intensive care
Intensive care medicine
Leukocytes
Liver
Liver - metabolism
Liver - physiopathology
Liver Function Tests
Male
Medical sciences
Metabolic Clearance Rate - drug effects
Middle Aged
Neutrophils
Plasma
Prospective Studies
Sepsis
Shock, Septic - drug therapy
Shock, Septic - metabolism
Shock, Septic - physiopathology
Vasodilator Agents - pharmacology
Vasodilator Agents - therapeutic use
title Effects of the stable prostacyclin analogue iloprost on the plasma disappearance rate of indocyanine green in human septic shock
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T20%3A10%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effects%20of%20the%20stable%20prostacyclin%20analogue%20iloprost%20on%20the%20plasma%20disappearance%20rate%20of%20indocyanine%20green%20in%20human%20septic%20shock&rft.jtitle=Intensive%20care%20medicine&rft.au=LEHMANN,%20Christian&rft.date=2000-10-01&rft.volume=26&rft.issue=10&rft.spage=1557&rft.epage=1560&rft.pages=1557-1560&rft.issn=0342-4642&rft.eissn=1432-1238&rft.coden=ICMED9&rft_id=info:doi/10.1007/s001340000662&rft_dat=%3Cproquest_cross%3E72501571%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c345t-2e029666d8d99e33395afd34446f854780052f6ae534d475e6eaaedafc4d6fbd3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=993566206&rft_id=info:pmid/11126272&rfr_iscdi=true